Clinical Trial Update: A Study of Necitumumab and Chemotherapy in Participants With Stage IV Squamous Non-Small Cell Lung Cancer [Phase 2]

View source ↗

Summary

A Phase 2 clinical trial evaluating necitumumab plus chemotherapy in stage IV squamous non-small cell lung cancer has completed with results posted in 2016.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Squamous Non-small Cell Lung Cancer

Drugs mentioned

• Necitumumab (necitumumab)

Snippet

Sponsor: Eli Lilly and Company | Conditions: Squamous Non Small Cell Lung Cancer | Phase 2 | Status: COMPLETED | Results posted: 2016-05-05